Trend
DailyDowntrend (starting)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns up above $0.88
Key levels
Resistance$0.74
Resistance$0.69
Support$0.61
Latest news & SEC filings
NewsDaré Bioscience says total awarded grant money tops $43M
All DARE news →Dare Bioscience is a biotech company dedicated to women's health. It develops treatments for conditions such as birth control, arousal difficulties, menstrual and pelvic discomfort, conception support, infections, vaginal wellness, and menopause symptoms. Its offerings include XACIATO, an FDA-approved vaginal gel for bacterial vaginosis, and DARE to PLAY, a compounded sildenafil cream. The company operates in the United States, relying on partners for manufacturing and commercialization.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DARE.
Start Free Trial →Valuation Verdict
FAIR
Methods Used
P/B, PEG
Fair Value
$0.94
27
Moat Score
NONE
4/9
Piotroski Score
-9.2
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
10429.4%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-150%
FCF Growth YoY
-309.6%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for DARE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:35:37 | $0.68 | 1,800 | $$1K | SELL |
| 23:06:56 | $0.65 | 3,500 | $$2K | BUY |
| 23:06:56 | $0.65 | 3,500 | $$2K | BUY |
| 20:45:42 | $0.70 | 10,000 | $$7K | SELL |
| 19:56:52 | $0.71 | 1,800 | $$1K | SELL |
5 dark pool trades shown · $$14K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Dare Bioscience, Inc. (DARE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Dare Bioscience, Inc. (DARE) is at $0.64, down 7.19% (-$0.05) at the Nov 12, 2026 close.
Latest DARE news — Oct 30, 2026: Daré Bioscience says total awarded grant money tops $43M
Analyst ratings for DARE: 3 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
DARE last reported on Aug 13, 2026: EPS -$0.20 vs -$0.30 expected — a beat of 32.6%.
DARE does not currently pay a dividend.
Support: $0.61. Resistance: $0.69, $0.74, $0.88.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Oct 30, 2026: Daré Bioscience says total awarded grant money tops $43M